Susan Hasty, Publisher
Table of Contents . . . July 17th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Colorectal Cancer - Vascular Modulator May Also Be Prognostic Indicator
Renal Cancer - Particle Embolization Reduces Blood Loss During Spinal Metastasis Surgery
Adverse Drug Effects - Interferon Is Cause Of Retinal Disease In Patients Treated For Melanoma
Breast Cancer - Older Women At Greater Risk If They Have High Bone Density
Breast Cancer - Side Effects Of Treatment Offer Research Direction
Non-Small Cell Lung Cancer - New Model Incorporates Biological Markers To Predict Patient Outcomes
Ovarian Cancer - Some Lipids Regulate Production of Proangiogenic Cytokine Interleukin-8
Anti-Angiogenesis - Novel Agent Works With Paclitaxel In Phase I Trial
Bladder Cancer - p53 Gene Therapy May Not Apply
Bone Marrow Cancer - Boosted Immunity Needed For Patients Who Undergo Stem Cell Transplants
Cancer Gene Therapy - Antisense Raf-1 Used In Phase I Clinical Trial
Cancer Vaccines - Tumor RNA Electroporation May Aid Development
Chronic Myeloid Leukemia - Mechanism Of Drug Resistance Demonstrated
Cord Blood Transplantation - Treatment For Adult Leukemia And Lymphoma Is Feasible
Diet and Nutrition - Two New Studies Support Health Benefits Of Black Tea
Glioma - Gene Therapy/Cisplatin Combined To Reduce Tumor Growth In Vivo
Head and Neck Cancer - Immunotherapy Shows Promise To Prevent Recurrence
Hodgkin Disease - Mini-BEAM Chemotherapy Linked To Poor Stem Cell Yields
Internet - VerticalNews Launch Uses NewsRx Artificial Intelligence Technology
Kidney Cancer - Angiogenic Factors Prevail In Wilms Tumor
Melanoma - Embryonic-Like Ability Of Aggressive Cancer Cells Studied
Myeloma - Patients Survive Longer When Vessel Growth Is Reduced In Bone Marrow
Ovarian Cancer - Anti-idiotypic Antibody Vaccine May Prolong Survival
Radiation Therapy - Weekly Blood Cell Counts May Be Unnecessary
Renal Cancer - Modified IL-18 Induces Antitumor Immunity
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.